References
- Santiago JV, Clemens AH, Clarke WL, et al. Closed-loop and open-loop devices for blood glucose control in normal and diabetic subjects. Diabetes 1979: 28(1):71–84
- Slama G, Hautecouverture M, Assan R, et al. One to five days of continuous intravenous insulin infusion on seven diabetic patients. Diabetes 1974: 23(9): 732–8
- Deckert T, Lorup B. Regulation of brittle diabetics by a pre-planned insulin infusion programme. Diabetologia 1976: 12(6):573–9
- Pickup JC, Keen H, Parsons JA, et al. Continuous subcutaneous insulin infusion: an approach to achieving normoglycaemia. Br Med J 1978: 1(6107): 204–7
- Tamboriane WV, Sherwin RS, Genel M, et al. Reduction to normal of plasma glucose in Juvenile diabetes by subcutaneous administration of insulin with a portable infusion pump. N Engl J Med 1979: 300(11):573–8
- Sherwin RS. Role of the liver in glucose homeostasis. Diabetes Care 1980: 3(2):261–5
- Press M, Walesky M, Sherwin R. Partial reversal of hepatic hyper-responsiveness to counterregulatory hormones with the insulin pump. Diabetes 1982: (Suppl 2) 31:267A
- Schiffrin A, Belmonte M. Comparison between continuous subcutaneous insulin infusion and multiple injections of insulin: a one-year prospective study. Diabetes 1982: 31:255–64
- Skyler J, Seigler D, Reeves M. A comparison of insulin regimens in insulin-dependent diabetes mellitus. Diabetes Care 1982: (Suppl 1) 5:11–8
- Seigler D, LaGreca A, Citrin W, et al. Psychological effects of intensification of diabetic control. Diabetes Care 1982: (Suppl 1)5:18–23
- Raskin P. Treatment of type I diabetes with portable infusion devices. Diabetes Care 1982: (Suppl 1)5:48–52
- Tamborlane W. Puklin J. Bergman M, et al. Long-term improvement of metabolic control with the insulin pump does not reverse diabetic microangiopathy. Diabetes Care 1982: (Suppl 1)5:58–64
- Stout RW. Diabetes and atherosclerosis—the role of insulin. Diabetologia 1979: 16(3):141–50
- Clarke WL, Haymond MW, Santiago JV. Overnight basal insulin requirements in fasting insulin-dependent diabetics. Diabetes 1980: 29(1):78–80
- Centers for Disease Control. Deaths among patients using continuous subcutaneous infusion pumps. Morbid Mortal Weekly Rep 1982 Feb 26:31: 80–7
- American Diabetes Association. Indications for use of continuous insulin delivery systems and self-measurement of blood glucose. Diabetes Care 1982: 5(2):140–1